Short-term esmolol improves coronary artery remodeling in spontaneously hypertensive rats through increased nitric oxide bioavailability and superoxide dismutase activity

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Arnalich Montiel, Ana ^a   González, María Carmen ^b   Delgado Baeza, Emilio ^a   Delgado Martos, María Jesús ^a   Condezo Hoyos, Luis ^b   Martos Rodríguez, Antonia ^a   Rodríguez Rodríguez, Pilar ^b   Quintana Villamandos, Begoña ^a,c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; CATALASE; ESMOLOL; NITRIC OXIDE; NITRITE; NITROPRUSSIDE SODIUM; SUPEROXIDE; SUPEROXIDE DISMUTASE; PROPANOLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL PARAMETERS; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY ARTERY MEDIA CROSS SECTIONAL AREA; CORONARY ARTERY REMODELING; CORONARY ARTERY WALL TO LUMEN RATIO; CORONARY ARTERY WALL WIDTH; CROSS-SECTIONAL STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; ENDOTHELIUM; ENZYME ACTIVITY; HEART RATE; HEART WEIGHT; HISTOLOGY; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN CONTENT; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRUCTURE ACTIVITY RELATION; ANIMAL; CORONARY BLOOD VESSEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; WISTAR KYOTO RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; CORONARY VESSELS; HYPERTENSION; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PROPANOLAMINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SUPEROXIDE DISMUTASE;

EID: 84899530881     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/531087     Document Type: Article

References (37)

1. Galderisi M., de Divitiis O., Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors. Journal of Cardiovascular Pharmacology 2008 51 6 523 531 2-s2.0-53249119849 10.1097/FJC.0b013e31817751a7
2. Agabiti-Rosei E., Rizzoni D., Regression of small resistance artery structural alterations in hypertension by appropriate antihypertensive treatment. Current Hypertension Reports 2010 12 2 80 85 2-s2.0-77953539721 10.1007/s11906-010-0093-7
3. Rehman A., Schiffrin E. L., Vascular effects of antihypertensive drug therapy. Current Hypertension Reports 2010 12 4 226 232 2-s2.0-77956268884 10.1007/s11906-010-0117-3
4. Schiffrin E. L., Vascular remodeling and endothelial function in hypertensive patients: effects of antihypertensive therapy. Scandinavian Cardiovascular Journal, Supplement 1998 32 47 15 21 2-s2.0-0031608151 (Pubitemid 28105219)
5. Rizzoni D., Agabiti-Rosei E., Structural abnormalities of small resistance arteries in essential hypertension. Internal and Emergency Medicine 2011 7 3 205 212 2-s2.0-79952105525 10.1007/s11739-011-0548-0
6. Yokoyama H., Averill D. B., Brosnihan K. B., Smith R. D., Schiffrin E. L., Ferrario C. M., Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy. American Journal of Hypertension 2005 18 7 922 929 2-s2.0-22844450180 10.1016/j.amjhyper.2005.01.009 (Pubitemid 41040262)
7. Fita G., Gomar C., Rovira I., Esmolol in anesthesiology: pharmacology and indications. Revista Española de Anestesiología y Reanimación 1999 46 9 401 414
8. Wiest D. B., Haney J. S., Clinical pharmacokinetics and therapeutic efficacy of esmolol. Clinical Pharmacokinetics 2012 51 6 347 356 2-s2.0-84860490448 10.2165/11631590
9. Quintana-Villamandos B., Delgado-Martos M. J., Sanchez-Hernandez J. J., Early regression of left ventricular hypertrophy after treatment with esmolol in an experimental rat model of primary hypertension. Hypertension Research 2013 36 5 408 413
10. Lunkenheimer P. P., Redmann K., Kling N., Three-dimensional architecture of the left ventricular myocardium. The Anatomical Record A, Discoveries in Molecular, Cellular, and Evolutionary Biology 2006 288 6 565 578 (Pubitemid 43848026)
11. Gundersen H. J. G., Bendtsen T. F., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J. R., Pakkenberg B., Sorensen F. B., Vesterby A., West M. J., Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Acta Pathologica, Microbiologica et Immunologica Scandinavica 1988 96 5 379 394 2-s2.0-0023913503
12. Giustarini D., Rossi R., Milzani A., Dalle-Donne I., Nitrite and nitrate measurement by griess reagent in human plasma: evaluation of interferences and standardization. Methods in Enzymology 2008 440 361 380 2-s2.0-44849133593 10.1016/S0076-6879(07)00823-3
13. Miranda K. M., Espey M. G., Wink D. A., A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide-Biology and Chemistry 2001 5 1 62 71 2-s2.0-0035709008 10.1006/niox.2000.0319 (Pubitemid 34146173)
14. Saleh L., Plieth C., A coelenterazine-based luminescence assay to quantify high-molecular-weight superoxide anion scavenger activities. Nature Protocols 2010 5 10 1635 1641 2-s2.0-77957571568 10.1038/nprot.2010.121
15. Hawkins C. L., Morgan P. E., Davies M. J., Quantification of protein modification by oxidants. Free Radical Biology and Medicine 2009 46 8 965 988 2-s2.0-63049127289 10.1016/j.freeradbiomed.2009.01.007
16. + channels mediate electrical stimulation-induced relaxation in the rat basilar artery. European Journal of Pharmacology 1999 372 2 179 186 2-s2.0-0032973032 10.1016/S0014-2999(99)00215-0 (Pubitemid 29251290)
17. Koprdová R., Cebová M., Kristek F., Long-term effect of losartan administration on blood pressure, heart and structure of coronary artery of young spontaneously hypertensive rats. Physiological Research 2009 58 3 327 335 2-s2.0-68649090964
18. Thybo N. K., Korsgaard N., Eriksen S., Christensen K. L., Mulvany M. J., Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 1994 23 5 659 666 2-s2.0-0028351850 (Pubitemid 24129363)
19. Sharifi A. M., Li J.-S., Endemann D., Schiffrin E. L., Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats. Journal of Hypertension 1998 16 4 457 466 2-s2.0-0031955899 10.1097/00004872-199816040- 00007 (Pubitemid 28195855)
20. Neglia D., Fommei E., Varela-Carver A., Mancini M., Ghione S., Lombardi M., Pisani P., Parker H., D'Amati G., Donato L., Camici P. G., Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension. Journal of Hypertension 2011 29 2 364 372 2-s2.0-78651337551 10.1097/HJH.0b013e328340a08e
21. Li J.-S., Sharifi A. M., Schiffrin E. L., Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR. Journal of Cardiovascular Pharmacology 1997 30 1 75 83 2-s2.0-0030612267 10.1097/00005344-199707000-00011 (Pubitemid 27527377)
22. Barone F. C., Campbell W. G. Jr., Nelson A. H., Feuerstein G. Z., Carvedilol prevents severe hypertensive cardiomyopathy and remodeling. Journal of Hypertension 1998 16 6 871 884 2-s2.0-0031836038 10.1097/00004872-199816060- 00019 (Pubitemid 28247971)
23. Xu Q., Chakravorty A., Bathgate R. A. D., Dart A. M., Du X.-J., Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats. Hypertension 2010 55 5 1260 1266 2-s2.0-77951499083 10.1161/HYPERTENSIONAHA.109.149369
24. Cebova M., Kristek F., Age-dependent ultrastructural changes of coronary artery in spontaneously hypertensive rats. General Physiology and Biophysics 2011 30 4 364 372 2-s2.0-83155193092 10.4149/gpb-2011-04-364
25. Brooks W. W., Conrad C. H., Robinson K. G., Colucci W. S., Bing O. H. L., L-arginine fails to prevent ventricular remodeling and heart failure in the spontaneously hypertensive rat. American Journal of Hypertension 2009 22 2 228 234 2-s2.0-58549101272 10.1038/ajh.2008.334
26. Tanaka M., Fujiwara H., Onodera T., Wu D. J., Hamashima Y., Kawai C., Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. British Heart Journal 1986 55 6 575 581 2-s2.0-0022591206 (Pubitemid 16092908)
27. Heagerty A. M., Aalkjaer C., Bund S. J., Korsgaard N., Mulvany M. J., Small artery structure in hypertension: dual processes of remodeling and growth. Hypertension 1993 21 4 391 397 2-s2.0-0027511750 (Pubitemid 23095149)
28. Deegan R., Wood A. J. J., β -receptor antagonism does not fully explain esmolol-induced hypotension. Clinical Pharmacology and Therapeutics 1994 56 2 223 228 2-s2.0-0028068863 (Pubitemid 24274190)
29. Amaral S. L., Michelini L. C., Effect of gender on training-induced vascular remodeling in SHR. Brazilian Journal of Medical and Biological Research 2011 44 9 814 826 2-s2.0-80053323714 10.1590/S0100-879X2011007500055
30. Wang L. L., Han Y., Guo Z., Han S. Q., Liu T., Esmolol activates endogenous neurokinin activity inhibiting infarction-induced arrhythmias in rats: novel mechanisms of anti-arrhythmia. Regulatory Peptides 2013 186 116 122
31. Sung R. J., Blanski L., Kirshenbaum J., MacCosbe P., Turlapaty P., Laddu A. R., Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia. Journal of Clinical Pharmacology 1986 26 A15 A26 2-s2.0-0022628836 (Pubitemid 16097794)
32. Wang Y., Zhang M., Liu Y., Liu Y., Chen M., The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats. Vascular Pharmacology 2011 54 1-2 36 43 2-s2.0-79952622857 10.1016/j.vph.2010.12.001
33. Szajerski P., Zielonka J., Sikora A., Adamus J., Marcinek A., Gebicki J., Kozlovski V. I., Drelicharz L., Chłopicki S., Radical scavenging and NO-releasing properties of selected beta-adrenoreceptor antagonists. Free Radical Research 2006 40 7 741 752 2-s2.0-37349088295 10.1080/10715760600690329
34. Horimoto H., Saltman A. E., Gaudette G. R., Krukenkamp I. B., Nitric oxide-generating β -adrenergic blocker nipradilol preserves postischemic cardiac function. Annals of Thoracic Surgery 1999 68 3 844 849 2-s2.0-0032744921 10.1016/S0003-4975(99)00809-7 (Pubitemid 29526849)
35. Veresh Z., Debreczeni B., Hamar J., Kaminski P. M., Wolin M. S., Koller A., Asymmetric dimethylarginine reduces nitric oxide donor-mediated dilation of arterioles by activating the vascular renin-angiotensin system and reactive oxygen species. Journal of Vascular Research 2012 49 4 363 372
36. Takai S., Kirimura K., Jin D., Muramatsu M., Yoshikawa K., Mino Y., Miyazaki M., Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling. Hypertension Research 2005 28 7 593 600 2-s2.0-25844490022 10.1291/hypres.28.593 (Pubitemid 41387290)
37. Feihl F., Liaudet L., Levy B. I., Waeber B., Hypertension and microvascular remodelling. Cardiovascular Research 2008 78 2 274 285 2-s2.0-42349107378 10.1093/cvr/cvn022 (Pubitemid 351556101)